2023
DOI: 10.1007/s00702-023-02624-7
|View full text |Cite|
|
Sign up to set email alerts
|

Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 47 publications
0
0
0
Order By: Relevance
“…In the context of construct validity and diagnostic analyses, the MoCA was considered as an outcome, both in accordance with the MDS recommendations to use this test for screening purposes in this population [ 50 ] and given that the MoCA is widely known to highly load on executive-based cognitive processes [ 48 ], as is the case with VF tests [ 51 ]. In support to such an approach, the MoCA has already been used earlier as an outcome measure for testing the validity and diagnostics of executive-loaded tests in both normotypical [ 48 , 52 ] and extrapyramidal populations [ 31 , 35 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the context of construct validity and diagnostic analyses, the MoCA was considered as an outcome, both in accordance with the MDS recommendations to use this test for screening purposes in this population [ 50 ] and given that the MoCA is widely known to highly load on executive-based cognitive processes [ 48 ], as is the case with VF tests [ 51 ]. In support to such an approach, the MoCA has already been used earlier as an outcome measure for testing the validity and diagnostics of executive-loaded tests in both normotypical [ 48 , 52 ] and extrapyramidal populations [ 31 , 35 ].…”
Section: Methodsmentioning
confidence: 99%
“…, normality thresholds—might be poorly sensitive and, at variance, disproportionately biased towards specificity [ 28 , 29 ]. Due to the detrimental entailments of such a stance towards clinical and research practice, researchers in the field of cognitive testing often commit to provide users with disease-specific cut-offs [ 28 – 37 ]—at least with regard to those brain disorders that are among the most prevalent and incident, as is the case for PD [ 35 39 ].…”
Section: Introductionmentioning
confidence: 99%